GlassScriptPhysician profile
Barbara Richardson
NPI 1215151394
$417.37
in general payments reported to CMS, 2019-2025
12 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.24 · 2022: $74.20 · 2023: $14.48 · 2024: $94.53 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $74.20 | 2022 | |
| Abbvie INC. | $48.86 | 2024 | |
| Exact Sciences Corporation | $47.66 | 2024-2025 | Cologuard Collection Kit |
| Insulet Corporation | $47.22 | 2025 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $46.54 | 2025 | Rexulti |
| Amgen INC. | $33.24 | 2021 | |
| Glaxosmithkline, LLC. | $29.85 | 2025 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $23.10 | 2025 | Voquezna |
| Insightec,INC | $20.05 | 2023-2024 | Exablate |
| Lundbeck LLC | $16.17 | 2025 | Rexulti |
| Novo Nordisk INC | $15.65 | 2024 | |
| Lilly USA, LLC | $14.83 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.